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Abstract
Background: Cognitive function and telomere length both decline with age. A correlation between these two
measures would suggest that they may be influenced by the same underlying age-related biological process.
Several studies suggest telomere length may be positively correlated with cognitive performance but the evidence
is equivocal. In this report, the relationships between telomere length and cognitive performance at Wave 2 and
cognitive change from Wave 1 to Wave 2 are assessed in two narrow age-range population cohorts.
Methods: We tested the hypothesis that leukocyte telomere length correlates positively with cognitive
performance and cognitive decline in two community cohorts of middle-aged (n = 351, 44-49 years) and older
(n = 295, 64-70 years) adults, who participated in two waves of a longitudinal study undertaken in the Canberra-
Queanbeyan region of Australia. Telomere length was estimated at Wave 2. Cognitive performance was measured
using the Symbol Digit Modalities Test, the immediate recall test of the California Verbal Learning Test, reaction
time (simple & choice) and the Trails Test Part B.
Results: Cross-sectionally at Wave 2, telomere length correlated with Symbol Digit Modalities Test scores (men)
and simple reaction time (women) for the older cohort only, although the latter finding was in the opposite
direction to that hypothesised. Telomere length measured at Wave 2 was not associated with cognitive change
from Wave 1 to Wave 2 for either cohort, except for two associations of small magnitude (immediate recall in the
older cohort, choice reaction time in older women), which were also in the contrary direction to that predicted.
Conclusions: These results do not give strong support to the hypothesis that leukocyte telomere length is
associated with either levels of cognitive performance or age-related cognitive change.
Background
Telomeres are DNA-protein structures that form pro-
tective caps at the termini of chromosomes and contri-
bute to genomic stability. The length of telomeres
decreases with increasing age [1-6], as a result of pro-
cesses such as the incomplete replication of the chromo-
somal ends at each cell division [5] and during periods
of elevated oxidative stress [7-11].
Cognitive decline also accompanies the ageing process
[12-14] and therefore may be correlated with telomere
length. Few studies have examined this relationship. Three
recent reports investigated cognitive performance and
leukocyte telomere length using population samples, with
mixed results. Harris et al. [15] found a single inverse
correlation between a verbal fluency test and telomere
length, but did not observe any significant relationships
with tests of non-verbal reasoning, verbal declarative
memory and a dementia-screening test in a sample of
79 year olds. In contrast, Valdes et al. [6], using a larger
and younger female sample with a wide age range (mean
age 50 yrs, range 19-78 yrs), found better performance was
correlated with longer telomere length on four of six
cognitive tests (simple reaction time, space span test,
paired associate learning and delayed matching to sample),
but not with pattern recognition and spatial working
memory tasks. The most robust findings were observed
for the space span and the delayed matching to sample
tests (partial r = 0.16), which remained significant after
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any medium, provided the original work is properly cited.adjustments for a wide range of variables. Whether these
results also apply to men is unclear. In the most recent
study, Yaffe et al. [16] observed that longer baseline telo-
mere length was associated with better baseline perfor-
mance on the Digit Symbol Substitution Test (DSST), but
not for change scores over seven years, in a large sample
of 70 to 79 year olds. In addition, a number of investiga-
tors have examined relationships with telomere length
using broader cognitive status questionnaires, such as the
Mini-Mental State Examination [MMSE, [17]]. The
MMSE has ceiling effects, which reduces its utility in
younger samples and in general these studies have found
negative results [15,18,19]. One study examined change in
MMSE scores over three years, but found no relationship
with baseline telomere length in a sample aged 85 and
over [19]. In contrast to these longitudinal results, Yaffe et
al. [16] observed that shorter baseline telomere length was
associated with greater decline in performance on the
Modified MMSE over seven years, but not with baseline
scores.
There are a number of methodological issues that
need to be considered when interpreting these findings.
The age and the age range of the sample employed in
such studies may be critical. The use of a sample with a
wide age-range may inflate observed relationships due
to age-related mean trends [20,21]. Therefore, cross-
sectional studies using a wide age range may not
provide the optimal design for evaluating the inter-
relationships between age-sensitive measures. Conver-
sely, the results of studies that employ a sample of a
specific age may not be generally applicable, as these
relationships may change across the lifespan. Sequential
narrow age-range cohorts or longitudinal designs are
more appropriate for clarifying such relationships. Long-
itudinal data would allow the examination of individual
rates of biological ageing with changes in telomere
length over successive waveso fd a t ac o l l e c t i o n .H o w -
ever, limited longitudinal data is available. Thus, more
research is required to address this question using both
men and women and to examine these relationships at
different stages of the lifespan, whilst controlling for
premorbid intelligence and other potential confounding
measures.
The present study examined the relationships between
telomere length and cognitive performance across a
range of tests in two narrow age-range cohorts - indivi-
duals aged in their 40s and 60s. Telomere length was
estimated in peripheral blood leukocytes at the second
wave of an ongoing longitudinal study. At Wave 2, we
predicted positive correlations between telomere length
and cognitive performance and that these relationships
would be stronger in the older age cohort, since both
cognitive performance and telomere length decline with
age. As we had baseline cognitive performance data
from four years earlier, we were able to correlate telo-
mere length at Wave 2 with measures of cognitive
decline. We predicted that those with shorter telomeres
would have greater cognitive decline over the preceding
four years.
Methods
Participants
Participants were drawn from a large longitudinal
Australian population-based study, the PATH Through
Life Project (PATH), which began in 1999 and collects
data every four years. This project investigates the
health and well-being of PATH participants by collect-
ing self-report data and assessing cognitive, physical and
health measures. The PATH study is comprised of three
narrow age-range cohorts and participants were aged
20-24, 40-44 (40+) and 60-64 (60+) years when
recruited into the study at Wave 1. The PATH sample
was recruited using the compulsory Australian electoral
roll records in the Queanbeyan and Canberra regions.
The majority of the interviews occurred in the partici-
pant’s home and participants entered self-report data
using hand-held computers under the supervision of
trained interviewers who also administered the physical
and cognitive tests. The Human Research Ethics
Committee of the Australian National University gave
approval for this study and all participants gave
informed consent. Further details of the study are
provided in Jorm et al. [22]. When the entire PATH
sample was compared with census information from the
recruitment areas, participants were similar in marital
status but tended to have greater rates of employment
and higher education levels [23]. Telomere length was
measured in a subsample of the 40+ and 60+ cohorts
who provided a blood sample for genetic analyses at the
second wave of data collection. A flow chart showing
the relationships between the telomere cohorts and the
PATH Study is illustrated in Figure 1. The recruitment
of the telomere cohorts is described in more detail
below.
Telomere 40+ Cohort
Over 25% of the 40+ cohort (n = 656) were invited to
participate in a brain imaging sub-study at Wave 2.
Most of the invited PATH participants expressed an
interest in participating (n = 503), with 372 donating a
blood sample. Telomere length data was available for
351 participants with a mean age of 47 years (SD = 1.4).
Compared to the remainder of the 40+ PATH cohort,
the 40+ telomere cohort were somewhat older but did
not differ in the proportions of sex, marital status, num-
ber of years of education, depression scale [24] or
Symbol Digit Modalities Test [25] results.
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All PATH 60+ cohort participants were invited to partici-
pate in a longitudinal brain imaging sub-study at Wave 1.
More than 80% indicated a willingness to participate
(n = 2076) and 479 participated at Wave 1. At Wave 2,
297 participants provided a blood sample before the
commencement of this study. Telomere length data was
available for the 297 participants, two of which were
identified as extreme outliers and omitted from further
analyses (z-scores > 3.29) [26]. The 60+ telomere cohort
had a mean age of 66.7 years (SD = 1.4) and did not differ
from the remainder of the 60+ PATH cohort with
respect to age, sex, years of education, the Mini-Mental
State Examination [17] or depression scale scores. How-
ever, the 60+ telomere cohort performed slightly better
on the Symbol Digit Modalities Test.
Telomere length measurement
Standard procedures were used to extract DNA from
peripheral blood leukocytes and positive control samples
[for further details, see [27]]. The positive controls
consisted of saliva and cell line genomic DNA and low
and high molecular weight telomere genomic DNA
standards (TeloTAGGG Telomere Length Assay Kit,
#2 209 136, Roche, Basel, Switzerland).
Estimation of telomere length was performed using a
quantitative real-time PCR (Q-PCR) technique [28]. In
this method, two Q-PCRs were undertaken for each
sample, a single-copy gene-specific Q-PCR (acidic ribo-
somal phosphoprotein, 36B4 or RPLP0) and a telomere-
specific Q-PCR. A telomere/single-copy gene (T/S) ratio
was calculated for each sample using the Q-PCR results
and normalised to the T/S ratio of a reference sample.
The normalised T/S ratio was used as an estimate of
relative telomere length.
Estimation of telomere length was performed separately
for each age cohort. The telomere and 36B4 Q-PCR assays
were performed in separate plates. Quadruplicate repli-
cates of each DNA sample (5-10 ng/reaction) were
dispensed using a liquid handling robot (EpMotion 5070,
Eppendorf, Hamburg, Germany) into duplicate plates and
dried down. Replicates were placed together in matching
positions on the duplicate plates. Dehydrated DNA was
resuspended in the relevant Q-PCR reaction mix, contain-
ing the appropriate primers, 1× Master Mix (Platinum
SYBR Green Master Mix, #11744-500, Invitrogen, Carls-
bad, CA, USA) and H2O to a total volume of 10 μl. For
the telomere Q-PCR reaction, the final concentration of
each of the primers was 500 nM (Tel1b: 5′ CGG TTT
GTT TGG GTT TGG GTT TGG GTT TGG GTT TGG
GTT 3′;T e l 2 b :5 ′ GGC TTG CCT TAC CCT TAC CCT
TAC CCT TAC CCT TAC CCT 3′; Cawthon, 2003, pers.
comm.). The final concentrations of the primers for the
36b4 Q-PCR reaction were 390 nM of the 36b4u primer
and 650 nM of the 36b4d primer [36b4u: 5′ CAG CAA
GTG GGA AGG TGT AAT CC 3′; 36b4d: 5′ CCC ATT
Figure 1 The relationships between the 40+ and 60+ Telomere Cohorts and the PATH Through Life (PATH) Study. The flow chart shows
the recruitment of the 40+ and 60+ Telomere Cohorts from the PATH Study. Telomere length was estimated at Wave 2 and cognitive
performance was measured at Waves 1 (w1) and 2 (w2) (except for the Trails B Test, which was measured at w2 only).
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assays were performed in a 7900HT Fast Real-Time PCR
machine (Applied Biosystems, Foster City, USA) at the
ACRF Biomolecular Research Facility (Australian National
University) using the cycling program of 50°C/2 min,
95°C/10 min, followed by 30 cycles of 95°C/30 secs and
56°C/1 min.
Q-PCR results were screened for outliers if the SD of
the cycle threshold [Ct] was greater than 0.2 [29]. If the
removal of a single outlier did not improve the SD of
t h er e p l i c a t eC t sf o ras a m p l e( ≤0.2), the assay was
repeated or the sample omitted. The variability of the
Q-PCR results was assessed for a set of positive controls
(human cell line and saliva DNA, n = 4 for the 40+
cohort and n = 3 for the 60+ cohort) that were assayed
in quadruplicate across five plates. For the 40+ cohort,
the mean coefficients of variation (CVs) for Ct scores
were 0.43% and 0.76% for the single-copy-gene and telo-
mere Q-PCR assays respectively. For the 60+ cohort, the
average CVs for Ct scores were 0.53% and 0.62% for the
single-copy-gene and telomere Q-PCRs respectively.
Relative telomere length (normalised T/S ratio) was
calculated using the comparative Ct method after verify-
ing that the telomere and 36B4 Q-PCRs had equivalent
amplification efficiencies [30]. Mean inter-assay CVs for
the relative telomere estimates (normalised T/S ratio)
across assays for the positive controls were 8.82% and
3.44% for the 40+ and 60+ cohorts respectively.
The relative telomere length results were validated
using an alternate method, the telomere restriction frag-
ment method (TRF) using the TeloTAGGG Telomere
Length Assay Kit (Roche) for a set of positive control
samples. In contrast to the Q-PCR method, the TRF
method estimates telomere length in kilobases. The two
methods were highly correlated for each age cohort
(r >0 . 9 ,p < .03, one-tailed). The regression equation
describing the relationship between the two methods
was also used to convert the relative telomere length
estimate to an absolute kilobase measure for each age
cohort. The kilobase estimate was used to assess if there
was a significant telomere length difference between the
two age cohorts. All primary analyses used the relative
telomere length measure.
Measures
Cognitive Measures
Information processing speed and attention were evalu-
ated using the Symbol Digit Modalities Test (SDMT)
[25]. Episodic memory (immediate recall) was assessed
using the first trial of the California Verbal Learning
Test [31]. Simple and choice reaction time were tested
using a small hand-held box with two red lights and
two depressible buttons located at the top of the box
[32]. For the simple reaction time test, one of the red
lights was activated and the participant was asked to
push the right hand button immediately. In the choice
reaction time test, the left or right red light was acti-
vated and the participant was asked to press the appro-
priate button. Simple reaction time was measured first,
using four blocks of 20 trials, followed by two blocks of
20 trials measuring choice reaction time. Any values less
than 0.1 secs or greater than 3.0 seconds were removed.
For each participant, means were then calculated for
each block and any values that exceeded 3 standard
deviations were eliminated [32]. The means (secs) were
then re-calculated. Executive function was assessed
using the Trails Test Part B [33]. Spot-the-Word Ver-
sion A [34] was used as a test of pre-morbid intelli-
gence. The Mini-Mental State Examination [17], a
screening test for cognitive impairment/dementia, was
administered to the 60+ cohort only. Whether telomere
length at Wave 2 was associated with decline in cogni-
tive performance from Wave 1 to Wave 2 was underta-
ken by assessing cognitive performance at Wave 2
residualised for Wave 1 scores. This analysis was not
undertaken for the Trails Test as this was not adminis-
tered at Wave 1.
Other Measures
Sociodemographic, lifestyle, health and anthropometric
information were self-reported. Occupational social class
(socioeconomic status) was determined using the
Australian Standard Classification of Occupations [35]
and participants were classified into one of three
categories, professional, white collar and blue collar.
Respondents were classified into three tobacco smoking
categories: current, past or never [36]. Weekly alcohol
consumption was estimated from responses to the Alco-
hol Use Disorders Identification Test (AUDIT) [37],
taking into account binge drinking episodes [23,38].
Antioxidant vitamin use was defined as the consumption
of vitamins and/or multivitamins 6-7 days/week for 6
months or more. Physical activity was measured using
questions from the UK Whitehall II Study [39,40] to cal-
culate the total number of hours of physical activity/week
[41]. The Goldberg Depression Scale [24] was used to
assess depressive symptoms and the current use of anti-
hypertensive medication was recorded. Two blood pres-
sure measurements were taken whilst the participant was
sitting and the mean used for analyses. A measure of
lung function, the forced expiratory volume in the first
second (FEV1), was determined using a Micro Spirom-
eter (Micro Medical Ltd, Rochester, Kent, UK). The high-
est of three FEV1 measurements was used in analyses.
Using the dominant hand, two trials of handgrip strength
were measured using the dynamometer (Smedley’s
Dynamo Meter, Tokyo) and the mean recorded.
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The relative telomere length variable was log10 trans-
formed to improve the normality of the distribution.
Similarly, alcohol consumption, physical activity, body
mass index (kg/m
2) and the cognitive measures of reac-
tion time (simple and choice) and the Trails Test were
also log10 transformed. Missing data were minimal
except for the measure of physical activity, where data
was imputed. Missing values for physical activity were
replaced with the median for the entire PATH Cohort
when stratified by age group for each frequency of activ-
ity category except for ‘never/hardly ever’ when the
missing value was replaced with zero. The relevant ana-
lyses were adjusted for the telomere length covariates,
alcohol consumption, physical activity and systolic blood
pressure and for age, sex and pre-morbid intelligence
using Spot-the-Word scores.
Most of the analyses were undertaken within each age
cohort. Due to sex differences on most measures, the
analyses were also undertaken separately for men and
women. Simple bivariate and partial correlations (Pear-
son’s and non-parametric) were undertaken to assess
the relationships between continuous variables. Indepen-
dent t-tests, analysis of variance (ANOVA) or c
2 tests
were used to assess the differences between groups.
Generalized linear models were used to assess the asso-
ciation between telomere length at Wave 2 and cogni-
tive change from Wave 1 to Wave 2. In order to
interpret the size of the effects, telomere length and the
dependent variables were converted to z-scores. Statisti-
cal tests were performed using SPSS v17 (SPSS Inc.,
Chicago, IL, USA) and a p value of < 0.05 was consid-
ered significant.
Results
Descriptive statistics for the two age cohorts are given in
Table 1. Fewer women were present in the 60+ cohort
compared to the 40+ cohort (46.4% vs. 55.8%). There
were more current smokers in the younger cohort and
the older cohort undertook more hours of physical
activity. Compared to the younger cohort, more 60+
cohort individuals consumed daily antioxidant vitamins
and a higher proportion was hypertensive. There was a
significant difference in telomere length between the
two age cohorts with the 40+ cohort having longer telo-
meres (median = 5.65 kb, IQR = 5.15-6.52) than the
60+ cohort (median = 4.69 kb, IQR = 4.42-5.03) (p <
0.0001, equal variances not assumed). Age was not cor-
r e l a t e dw i t ht e l o m e r el e n g t hw i t h i ne a c ho ft h en a r r o w
age-range cohorts (p > 0.05).
Potential covariates of telomere length identified from
prior studies include sex [42-45], antioxidant vitamin
use [46,47], physical activity [48], alcohol consumption
[15], tobacco smoking [49,50] and socioeconomic status
[51]. There were no significant differences in telomere
length between men and women, nor for antioxidant
vitamin use, smoking or socioeconomic status (p >
0.05). For the 60+ cohort only, increased alcohol con-
sumption was correlated with shorter telomere length
(r = -0.155, p = 0.008). Telomere length was also corre-
lated with physical activity for the 40+ cohort (r =
-0.114 p = 0.034) and systolic blood pressure for 40+
women (r = 0.157, p = 0.029). The results of these ana-
lyses are detailed in additional file 1 (Supplemental
Table S1).
Cross-sectional analyses revealed no significant correla-
tions between telomere length and cognitive performance
for the 40+ cohort or for men or women of this cohort
(Table 2). For the entire older cohort, telomere length was
not associated with performance on any of the cognitive
Table 1 General characteristics by age cohort
Characteristic 40+ (n = 351) 60+ (n = 295)
Telomere Length (kb) 5.65 [5.15-6.52]
a
5.88 ± 0.98
b
4.69 [4.42-5.03]
a
4.74 ± 0.47
b
Sociodemographic
Sex Men 155 (44.2%)
c 158 (53.6%)
c
Women 196 (55.8%)
c 137 (46.4%)
c
Age (yr) 46.8 ± 1.4
b 66.7 ± 1.4
b
Age range (yr) 44-49 64-70
Education (yr) 14.80 ± 2.25
b 14.10 ± 2.62
b
Lifestyle
Smoking Status Current 45 (12.8%)
c 17 (5.8%)
c
Past 117 (33.3%)
c 107 (36.3%)
c
Never 189 (53.8%)
c 171 (58.0%)
c
Alcohol (drinks/week) 4.00 [1.00-9.00]
a 4.00 [0.38-9.00]
a
Physical activity (hr)/
week
10.50 [5.50-
17.00]
a
14.00 [8.00-
24.75]
a
Daily antioxidant vitamin
use
48 (13.7%)
c 71 (24.1%)
c
Health
Obesity
d 72 (21.8%)
c 60 (20.5%)
c
Definite hypertension
e 46 (13.5%)
c 133 (45.9%)
c
Physical Function
Grip Strength
f 21.598 ±
6.081
b
18.533 ±
5.153
b
Lung Function
g 1.859 ± 0.362
b 1.513 ± 0.342
b
kb = kilobase.
a median [interquartile range].
b mean ± standard deviation.
c frequency (%).
d Obesity is defined as a body mass index (kg/m
2)o f≥30.00.
e Hypertension is defined as either the current use of anti-hypertensive
medication or having a mean systolic blood pressure measurement ≥ 160 mm
Hg and/or a mean diastolic blood pressure ≥95 mm Hg.
f Handgrip strength (kg) adjusted for height (m).
g Lung function is the highest reading from three trials for forced expiratory
volume (L) in one second (FEV1), adjusted for height (m). Those with lung
conditions were excluded.
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adjusting for covariates (Spearman’s partial r = 0.135,
p = 0.025). When men and women were examined sepa-
rately, performance on the SDMT remained positively cor-
related with telomere length for men of the 60+ cohort
only; before (r =0 . 1 7 3 ,p = 0.031) and after adjustment for
covariates (Spearman’s partial r = 0.193, p = 0.018). These
relationships were in the direction expected, that is, better
cognitive performance was associated with longer telo-
mere length. Conversely, for 60+ cohort women, but not
men, a significant positive correlation between telomere
length and simple reaction time in the opposite direction
to that expected was observed. This relationship was sig-
nificant before (r = 0.185, p = 0.036) and after adjusting
for covariates (Spearman’sp a r t i a lr = 0.218, p = 0.018).
Cognitive performance test scores at the two waves of
data collection (Waves 1 & 2) are shown in Table 3.
Better cognitive performance was observed on most
cognitive tests for the younger cohort. For the older
cohort, cognitive performance decreased across the two
waves of data collection whereas for the 40+ cohort,
performance either slightly decreased or improved. As
indicated in Table 3, in general, telomere length at
Wave 2 was not associated with change in cognitive per-
formance over the two waves of data collection (Wave 1
to Wave 2) in either cohort (p > 0.05). The exceptions
were (i) a significant association between telomere
length and immediate recall for the entire 60+ cohort
(p = 0.049, B = -0.100, S.E. = 0.051) and (ii) a significant
association with choice reaction time for women of the
older cohort (p = 0.029, B = 0.169, S.E. = 0.078). How-
ever, the magnitude of the effects was small and in the
contrary direction to that expected.
Discussion
In general, telomere length was not associated with cog-
nitive performance in two narrow age-range cohorts of
middle-aged and older Australians. Although there was
a significant correlation between performance on the
Symbol Digit Modalities Test (SDMT) and telomere
length in the expected direction, a significant association
was also observed in the contrary direction for telomere
length and simple reaction time. These relationships
were modified by age group, with the significant findings
being observed in the older age cohort only. Sex differ-
ences were also observed, with a significant correlation
between telomere length and SDMT scores found for
men only, whereas a significant association between tel-
omere length and simple reaction time was observed for
women only. Telomere length at Wave 2 was not corre-
lated with cognitive change over a four-year period from
Wave 1 to Wave 2, except for two associations in the
older cohort (immediate recall and choice reaction time
for women) of small effect size and in the contrary
direction to that hypothesised.
Consistent with the present results, Yaffe et al. [16]
observed a positive association between telomere length
and a similar cognitive test to the SDMT, the DSST, but
not with change scores, in a slightly older community
sample. This suggests that leukocyte telomere length
may be associated with cross-sectional performance on
tests of information processing speed and attention in
older samples. On the other hand, the generally negative
results of the current study concur with those of Harris
et al. [15] who in the main did not find any significant
Table 2 Cross-sectional correlations between telomere
length and cognitive scores (Wave 2) by age cohort and
sex
Cognitive Test Age Cohort rP - value Partial rP - value
Immediate recall 40+ 0.021 0.694 -0.019 0.728
40+ Men -0.026 0.747 -0.053 0.520
40+ Women 0.037 0.609 0.001 0.985
60+ -0.065 0.263 -0.108 0.073
60+ Men -0.038 0.636 -0.125 0.130
60+ Women -0.114 0.186 -0.094 0.303
SDMT
a 40+ -0.013 0.809 -0.001 0.979
40+ Men -0.107 0.186 -0.111 0.176
40+ Women 0.061 0.393 0.088 0.231
60+ 0.104 0.076 0.135 0.025*
60+ Men 0.173 0.031* 0.193 0.018*
60+ Women 0.050 0.563 0.087 0.340
Simple RT
b 40+ -0.033 0.543 -0.014 0.795
(secs) 40+ Men -0.060 0.467 0.016 0.849
40+ Women -0.064 0.381 -0.047 0.528
60+ 0.076 0.204 0.099 0.108
60+ Men -0.051 0.529 0.005 0.950
60+ Women 0.185 0.036* 0.218 0.018*
Choice RT 40+ 0.000 0.997 -0.009 0.871
(secs) 40+ Men 0.007 0.929 0.013 0.880
40+ Women -0.022 0.767 -0.025 0.732
60+ 0.017 0.770 0.036 0.556
60+ Men -0.121 0.134 -0.051 0.546
60+ Women 0.139 0.114 0.136 0.143
Trails B 40+ 0.045 0.398 0.036 0.506
40+ Men 0.139 0.085 0.137 0.095
40+ Women -0.038 0.601 -0.063 0.388
60+ -0.024 0.680 -0.025 0.674
60+ Men -0.095 0.239 -0.080 0.331
60+ Women 0.036 0.678 0.017 0.852
TL = telomere length; SDMT = Symbol Digit Modalities Test; RT = reaction
time;
*p < 0.05. Partial correlations were adjusted for age, Spot-the-Word, alcohol
consumption, physical activity, systolic blood pressure and sex were
appropriate.
a For SDMT, outliers (z-scores > +3.29 or < -3.29) were omitted from the
bivariate correlations for the 60+ cohort.
b For simple reaction time, outliers (z-scores > +3.29 or < -3.29) were omitted
from the bivariate correlations.
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cognitive tests in an older sample of 79 year olds. The
authors found one significant relationship between a
test of executive function (verbal fluency) and telomere
length in the opposite direction to that expected, which
the authors speculate was attributable to chance. In the
current study, a different test of executive function was
employed, the Trails B Test, but no significant correla-
tions with telomere length were observed in either age
cohort. Valdes et al. [6] found a significant relationship
between telomere length and simple reaction time in
the expected direction, but this did not remain signifi-
cant after controlling for a wide range of measures.
Although the present study did find a significant rela-
tionship between telomere length and simple reaction
time for older women, this was in the opposite direction
to that predicted and observed by Valdes et al. [6].
Moreover, Valdes et al. reported that telomere length
contributed 2.3% or less to the variance observed in
cognitive ability. All of these studies vary in the samples
used and, in general, different cognitive tests were
employed.
Few studies have examined cognitive change and telo-
mere length and the findings are equivocal [15,16,19].
Further longitudinal studies spread across the lifespan
that use a wide variety of cognitive tests are required to
adequately address this question.
In the current study, as expected, mean telomere
length was significantly shorter for the older age cohort.
Conversely, telomere length was not correlated with age
within each age cohort, which may be due to the use of
narrow age-range cohorts and the wide inter-individual
variability observed in telomere length for individuals of
the same chronological age [52]. The kilobase estimates
of telomere length are similar to prior reports that have
been calculated using the relative telomere length
method [4,46,53]. The rate of telomere loss based on
t h ed i f f e r e n c eb e t w e e nt h et w oa g ec o h o r t s( ~ 5 0b a s e
Table 3 Cognitive performance at the two waves of data collection (Wave 1 and Wave 2) for each telomere cohort
Cognitive Test Age Cohort n at Wave1 Wave 1 Mean ± SD
a or
Median [IQR]
b
n at Wave 2 Wave 2 Mean ± SD
a or Median [IQR]
b P-value
c
Immediate recall
d 40+ 350 8.21 ± 2.18
a 351 8.33 ± 2.24
a 0.694
40+ Men 155 7.69 ± 1.97
a 155 7.74 ± 2.05
a 0.612
40+ Women 195 8.63 ± 2.26
a 196 8.80 ± 2.27
a 0.665
60+ 295 7.51 ± 2.13
a 293 7.16 ± 1.99
a 0.049*
60+ Men 158 7.11 ± 2.05
a 157 6.86 ± 1.86
a 0.307
60+ Women 137 7.96 ± 2.14
a 136 7.51 ± 2. 08
a 0.102
SDMT
e 40+ 349 61.30 ± 8.79
a 350 60.94 ± 8.59
a 0.966
40+ Men 155 60.70 ± 8.65
a 155 60.45 ± 8.67
a 0.442
40+ Women 194 61.78 ± 8.89
a 195 61.32 ± 8.54
a 0.416
60+ 294 51.40 ± 8.00
a 293 50.58 ± 8.23
a 0.058
60+ Men 158 51.42 ± 7.65
a 156 50.93 ± 7.71
a 0.059
60+ Women 136 51.38 ± 8.41
a 137 50.19 ± 8.79
a 0.292
Simple RT 40+ 342 0.224 [0.206-0.245]
b 342 0.226 [0.210-0.250]
b 0.833
40+ Men 150 0.216 [0.200-0.234]
b 150 0.223 [0.207-0.243]
b 0.553
40+ Women 192 0.228 [0.211-0.257]
b 192 0.232 [0.213-0.260]
b 0.390
60+ 285 0.238 [0.218-0.267] 285 0.252 [0.228-0.290]
b 0..498
60+ Men 150 0.234 [0.213-0.254]
b 154 0.243 [0.223-0.285]
b 0.354
60+ Women 135 0.252 [0.221-0.281]
b 131 0.260 [0.235-0.302]
b 0.117
Choice RT 40+ 338 0.283 [0.266-0.306]
b 341 0.288 [0.263-0.310]
b 0.700
40+ Men 150 0.278 [0.262-0.300]
b 149 0.278 [0.259-0.302]
b 0.784
40+ Women 188 0.287 [0.269-0.312]
b 192 0.295 [0.265-0.316]
b 0.615
60+ 283 0.314 [0.291-0.334]
b 285 0.318 [0.288-0.349]
b 0.068
60+ Men 149 0.315 [0.289-0.330]
b 154 0.317 [0.283-0.345]
b 0.989
60+ Women 134 0.313 [0.292-0.338]
b 131 0.318 [0.294-0.354]
b 0.029*
IQR = interquartile range; SD = standard deviation; Immediate recall is from the California Verbal Learning Test; SDMT = Symbol Digit Modalities Test; RT =
reaction time; Descriptive statistics are given using the raw data. * p < 0.05
a Mean ± standard deviation
b Median [interquartile range]
c Covariates were Wave1 performance on the relevant cognitive test, age, Spot-the-Word, systolic blood pressure, physical activity, alcohol consumption and
where appropriate sex
d For the immediate recall descriptives, outliers (z-scores > +3.29 or < -3.29) were omitted
e For the SDMT descriptives, outliers (z-scores > +3.29 or < -3.29) were omitted
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data [45,54-58].
There are limitations to the present study. Ideally, to
examine the relationship between telomeres and cognition,
telomere length should be measured in neural tissue such
as neuronal or glial cells. However, access to such samples
is not practical. Although telomere length in leukocytes
may act as a surrogate marker for telomere length in other
tissues [59-62], recent research suggests it may not be
applicable to all cell types [63]. The current study was
underpowered (54-75%) to detect correlations of similar
size to the Valdes et al. [6] report; however, the study had
sufficient power (> 80%) to detect correlations of medium
to large effect size (r ≥ 0.3) [64]. The variability of telomere
length estimation as measured by the mean inter-assay
coefficient of variation (CV) differed for the two cohorts.
The larger measurement error for the 40+ cohort (8.8%)
may have attenuated any significant relationships of small
to medium effect size. Nevertheless, the inter-assay CV
results of the present study fall within the range reported
in prior studies, which is generally less than 10% but can
range from 5.3 to 28.0% [65-68]. The comparatively low
i n t e r - a s s a yC Vf o rt h e6 0 +c o h o r t( 3 . 4 % )a n dt h el a c ko f
significant relationships in general for this cohort, suggests
that there are either no associations between the cognitive
measures and telomere length or they are of small effect
size. The minimisation of telomere length measurement
error should be an important priority in future telomere
studies. Another limitation is that longitudinal telomere
length data is not available. Thus comparisons of the rates
of telomere attrition with cognitive change were not possi-
ble. Further, not all possible telomere length covariates
were measured, such as paternal age at the participant’s
birth [69].
The main strength of this study is the use of two nar-
row age-range cohorts that differ in age by twenty years
allowing the examination of the relationships between
cognition and telomere length to be investigated at two
different stages of the lifespan. It also examined the rela-
tionships between cross-sectional telomere length and
longitudinal performance on age-sensitive cognitive tests
over four years. In the future, as further waves of cogni-
tive data are collected, it will allow the examination of
the relationships between prospective cognitive decline
measures over a longer time period with ‘baseline’ telo-
mere length.
Conclusions
The results of the current study do not lend support to
the hypothesis that leukocyte telomere length is asso-
ciated with general cognitive performance or age-related
cognitive change. Whether telomere length is a marker
of cognitive ageing in the general population requires
more data from a comprehensive range of cognitive
tests, particularly from longitudinal and/or sequential
narrow age-range cohort study designs.
Additional material
Additional file 1: Supplemental Table S1: Associations between
relative telomere length and potential confounders for the two age
cohorts
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